Investors looking for stocks in the Large Cap Pharmaceuticals sector might want to consider either Novartis (NVS) or Eli Lilly (LLY). But which of these two companies is the best option for those ...

While competitors like Eli Lilly and Novo Nordisk race to capture the booming weight-loss drug market, Novartis is steering ...

Since the 2023 financing round, Flare’s lead program FX-909 has moved into a phase 1 clinical trial for patients with ...

As Novartis builds an empire of radiopharmaceuticals, the Swiss pharma has ramped up legal actions against its competitors. | As Novartis builds an empire of radiopharmaceuticals, the Swiss pharma has ...

Novartis’ Vas Narasimhan, and Eli Lilly’s David Ricks backed the proposals to end rebates paid to pharmacy benefit managers and health insurers that push up the prices of their diabetes medicines.

SAN ANTONIO — Oral semaglutide 25 mg appears to be just as effective in promoting weight loss and other beneficial outcomes ...

Let's look at five biotech and drug companies, AZN, NVAX, AXSM, TBPH and PRTA, slated to release their third-quarter 2024 ...

Recent health industry updates reveal Sun Pharma's profit surge due to specialty drugs, Pfizer's strategic focus under ...

Bearing that in mind, we used TipRanks’ Stock Comparison Tool to place Eli Lilly (LLY), Novartis (NVS), and Intuitive Surgical (ISRG) against each other to find the healthcare stock with a ...

Not long after Basel, Switzerland, was selected as the next host of the annual Eurovision Song Contest, hometown pharma ...

Eli Lilly has teamed up with insitro to develop ... Givlaari (givosiran), Oxlumo (lumasiran), Amvuttra (vutrisiran) and Novartis’s Leqvio (inclisiran). Under the third agreement, insitro and ...

Pfizer, Sanofi and others report Q3 beats; AbbVie, Roche and Novartis strike big deals; the 2024 presidential election looms; ...